Half-dose fulvestrant plus anastrozole as a first-line...

BMJ Open 2020 / 08 Vol. 10; Iss. 8

Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis

Huang, Xiaoting, Weng, Xiuhua, Lin, Shen, Liu, Yiwei, Luo, Shaohong, Wang, Hang, Ming, Wai-kit, Huang, Pinfang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-036107
Date:
August, 2020
File:
PDF, 617 KB
2020
Conversion to is in progress
Conversion to is failed